- PATIENT CARE
- JOIN US
- FIND A DOCTOR
The mission of SUNY Upstate Medical University is to improve the health of the communities we serve through education, biomedical research, and health care. Clinicians have a primary responsibility to work for patients’ welfare. Researchers are dedicated to furthering scientific biomedical understanding in ways that can be translated into products and techniques that benefit society. To achieve these ends, SUNY Upstate’s faculty, staff, and students interact and, at times, partner with the pharmaceutical, medical device and other companies and organizations, such as federal, state and local governments, foundations and individuals.
As part of SUNY Upstate Medical University’s research missions, Upstate faculty, staff, and students are encouraged to engage in appropriate outside relationships with private industry and other organizations and individuals who sponsor research. Without these relationships our academic research could not be translated into products that benefit society. A principled partnership between the academic community and these research sponsors is essential if we are to realize the promise of biomedical research. Such collaborations must be free of conflicts of interest to assure that research is objectively designed, conducted, and reported.
This policy establishes expectations for behavior in relations with the pharmaceutical, medical device, biotechnology, and other companies (hereafter referred to as Industry), and other organizations in accordance with the expressed values of SUNY Upstate Medical University. It is intended to guide interactions with Industry and other organizations so that institutional and professional integrity is maintained while we care for patients, teach clinicians, scientists, and students, and carry out biomedical research.
In addition, this policy promotes objectivity in research by establishing standards that provide a reasonable expectation that the design, conduct and reporting of sponsored research will be free from bias resulting from investigator conflicts of interest, including financial conflicts of interest.